Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Offerings

Group By Ticker
Sort By
Newest | Oldest
Read More
4 minute read
  • Biotech
  • Cannabis
  • Financing
  • Global
  • Health Care
  • Legal
  • Management
  • Offerings
  • Psychedelics
  • Regulations

Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, ‘Synthetic Surprise,’ UK’s Harm Reduction Hub And More

By Lara Goldstein
January 26, 1:33 PM
Discover the latest research on psychedelics, from anti-inflammatory effects to end-of-life therapy. New journal issue and online course available.

AWKNF

Read More
2 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • Movers
  • News
  • Offerings
  • Trading Ideas

What’s Going On With Anti Cancer Focused Processa Pharmaceuticals Stock Today?

By Vandana Singh
January 26, 12:16 PM
Processa Pharmaceuticals stock surge - 148.8% gain to $5.10 post Next Generation Capecitabine (NGC-Cap) Phase 1b success.

PCSA

Read More
1 minute read
  • News
  • Offerings

Aptose Announces Pricing Of Underwritten Offering Of 4,912,280 Shares At $1.71 Per Share And Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

By Benzinga Newsdesk
January 26, 9:04 AM
SAN DIEGO and TORONTO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ:APTO, TSX:APS), a clinical-stage precision oncology company developing highly differentiated

APTO

Read More
3 minute read
  • News
  • Offerings

On January 24, 1847 Holdings Announced An Offering Of Up To 2,673,797 Common Shares At A Price Of $1.87 Per Share

By Benzinga Newsdesk
January 25, 12:01 PM
We are offering up to 2,673,797 common shares, based on an assumed public offering price of $1.87 per share, the closing price of our common shares on January 19, 2024. We are also offering to each purchaser of common

EFSH

Read More
2 minute read
  • News
  • Offerings

Jeffs’ Brands Announces Pricing of $7.275M Private Placement; In Connection With The Private Placement, The Company Will Issue An Aggregate Of 2,704,461 Units And Pre-Funded Units

By Benzinga Newsdesk
January 25, 10:40 AM
Jeffs' Brands Ltd ("Jeffs' Brands" or the "Company") (NASDAQ:JFBR, JFBRW)))), a data-driven e-commerce company operating on the Amazon Marketplace, today announced that it has entered into securities purchase agreements

JFBR

Read More
1 minute read
  • News
  • Offerings

eFFECTOR Therapeutics Announces $15M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

By Benzinga Newsdesk
January 25, 9:11 AM
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) (the "Company"), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that it has entered into a

EFTR

Read More
1 minute read
  • News
  • Offerings

Tourmaline Bio Announces Proposed Public Offering Of Common Stock; No Size Or Amount Disclosed

By Benzinga Newsdesk
January 24, 5:34 PM
Tourmaline Bio, Inc. ("Tourmaline") (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory

TRML

Read More
1 minute read
  • Biotech
  • Financing
  • General
  • Health Care
  • Movers
  • News
  • Offerings
  • Trading Ideas

Why Is Cancer Focused Kura Oncology Stock Is Trading Higher Today?

By Vandana Singh
January 24, 12:16 PM
Latest surge in Kura Oncology shares with a $150 million private placement announcement. Cash runway extended into 2027.

KURA

Read More
2 minute read
  • News
  • Offerings

On January 19, Connexa Sports Technologies Inc Entered Into Securities Purchase Agreements With Three Investors

By Benzinga Newsdesk
January 24, 11:11 AM
- SEC Filing On January 19, 2024, Connexa Sports Technologies Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreement") with three investors (the "Investors") for the

CNXA

Read More
1 minute read
  • Movers
  • News
  • Offerings

What’s Going On With BlackBerry (BB) Stock?

By Adam Eckert
January 24, 10:15 AM
After the market close on Tuesday, BlackBerry said it intends to offer $160 million worth of Convertible Senior Notes due 2029 in a private offering.

BB

Posts pagination

Previous 1 … 20 21 22 … 166 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service